GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » Ending Cash Position

Syntara (ASX:SNT) Ending Cash Position : A$18.07 Mil (As of Dec. 2024)


View and export this data going back to 2003. Start your Free Trial

What is Syntara Ending Cash Position?

Syntara's Ending Cash Position for the quarter that ended in Dec. 2024 was A$18.07 Mil.

Syntara's quarterly Ending Cash Position declined from Dec. 2023 (A$5.69 Mil) to Jun. 2024 (A$3.52 Mil) but then increased from Jun. 2024 (A$3.52 Mil) to Dec. 2024 (A$18.07 Mil).

Syntara's annual Ending Cash Position increased from Jun. 2022 (A$8.94 Mil) to Jun. 2023 (A$9.23 Mil) but then declined from Jun. 2023 (A$9.23 Mil) to Jun. 2024 (A$3.52 Mil).


Syntara Ending Cash Position Historical Data

The historical data trend for Syntara's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syntara Ending Cash Position Chart

Syntara Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.76 18.71 8.94 9.23 3.52

Syntara Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.45 9.23 5.69 3.52 18.07

Syntara Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Syntara's Ending Cash Position for the fiscal year that ended in Jun. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=9.23+-5.71
=3.52

Syntara's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=3.521+14.55
=18.07


Syntara Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Syntara's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Syntara Business Description

Traded in Other Exchanges
Address
20 Rodborough Road, Unit 2, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring, and neuroinflammation.